logo

CLDX

Celldex Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

CLDX fundamentals

Celldex Therapeutics (CLDX) expects to report earnings on Aug 14, 2025, with estimated revenue of 1.13M (YoY -54.76%), and EPS at -0.84 (YoY -55.56%).
Revenue estimate / YoY
1.13M
-54.76%
EPS estimate / YoY
-0.84
-55.56%
Report date
Aug 14, 2025
EPS
Revenue

Revenue & Expenses

CLDX has released its 2025 Q1 earnings report, with revenue of 695.00K, reflecting a YoY change of 345.51%, and net profit of -53.80M, showing a YoY change of -63.97%. The Sankey diagram below clearly presents CLDX's revenue sources and cost distribution.

Key Indicators

Celldex Therapeutics (CLDX) key financial stats and ratios, covering profitability, financial health, and leverage.
Celldex Therapeutics (CLDX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Celldex Therapeutics (CLDX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Celldex Therapeutics (CLDX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Celldex Therapeutics (CLDX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Celldex Therapeutics (CLDX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield